diagnostics

Health By Matthew Herper

Test makers are moving fast, but the coronavirus may be moving faster

In the Lab By Matthew Herper

CRISPR pioneer Doudna opens lab to run Covid-19 tests

Pharmalot By Ed Silverman

Roche backpedals and agrees to provide a solution for Covid-19 tests in the Netherlands

Health By Andrew Joseph

The next frontier in coronavirus testing: Identifying the full scope of the pandemic, not just individual infections

Health Tech By Erin Brodwin

Startups touting at-home coronavirus tests suspend plans after FDA warning

First Opinion By Farzad Mostashari and Ezekiel J. Emanuel

We need smart coronavirus testing, not just more testing

Pharmalot By Ed Silverman

FDA moves to boost coronavirus testing capacity by giving states more power

Health By Lev Facher

Trump administration says it will launch mobile coronavirus test system this week

Health By Matthew Herper

Thermo Fisher to produce millions of coronavirus diagnostic tests

Matt's Take By Matthew Herper

Coronavirus testing is starting to get better — but it has a long way to go

Biotech By Rebecca Robbins

Microbial signatures in the blood could offer new avenue for liquid biopsies to detect cancer

Health By Matthew Herper and Helen Branswell

Shortage of crucial chemicals creates new obstacle to U.S. coronavirus testing

Biotech By Jonathan Saltzman — Boston Globe

Thermo Fisher buys Dutch diagnostics company for $11.5 billion

Health Tech By Rebecca Robbins

FDA names genes that may interact with specific drugs, offering clarity to genetic testing industry

First Opinion By Thomas Grogan

A doctor-entrepreneur’s guide to socially responsible capitalism

Business By Erin Brodwin

23andMe laying off 14% of employees amid slump in DNA spit kit sales

First Opinion By Eli Cahan

The emergence of laboratory benefits managers: PBM déjà vu?

Health By Jonathan Saltzman — Boston Globe

Can a simple eye exam replace costly and invasive Alzheimer’s diagnostic procedures?

First Opinion By Robert Truog

New guidelines on severe brain injury complicate already difficult decisions

Health By Associated Press

Scientists close in on blood test for Alzheimer’s

Health Tech By Shraddha Chakradhar

5 questions facing companies developing liquid biopsies for cancer screening

Opinions Plus By Grey Wilkinson

Biomarkers provide a bridge to the next frontier in immuno-oncology

First Opinion By Bob Thomas

Genetic testing: the next big arena for fraud?

Biotech By Kate Sheridan and Matthew Herper

Thrive, with $100 million, strides into the crowded race to develop a blood test to detect cancer

First Opinion By Madhukar Pai, Catharina Boehme, and Ilona Kickbusch

Diagnostics are essential for universal health coverage to succeed

In the Lab By Shraddha Chakradhar

A smartphone app could help diagnose ear infections more accurately — and at home

Business By Rick Berke

From protégée to whistleblower: A former Theranos scientist says Elizabeth Holmes should ‘come forward and apologize’

In the Lab By Shraddha Chakradhar

An experimental test may help confirm cases of chronic fatigue syndrome

First Opinion By Rahul Desikan

I have ALS. I wish a polygenic analysis had told me it was coming